全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
华西医学  2010 

左氧氟沙星联合阿奇霉素治疗老年难治性呼吸道感染的临床分析

, PP. 2174-2176

Keywords: 老年,难治性呼吸道感染,左氧氟沙星,阿奇霉素,生物被膜

Full-Text   Cite this paper   Add to My Lib

Abstract:

【】 目的 探讨左氧氟沙星联合阿奇霉素治疗老年难治性呼吸道感染的疗效及安全性。 方法 选择2005年2月-2010年9月收治的高龄难治性呼吸道细菌感染患者68例,随机分为治疗组和对照组。治疗组34例,给予左氧氟沙星联合阿奇霉素;对照组34例,给予左氧氟沙星,两组总疗程皆为15d。观察两组患者的临床疗效、细菌清除率和不良反应。 结果 治疗组的总有效率为64.71%,对照组总有效率为32.35%,两组差异有统计学意义(P0.05)。结论 左氧氟沙星联合阿奇霉素治疗老年难治性呼吸道感染疗效高,能有效清除细菌,不良反应较少,值得临床推广应用。?【Abstract】 Objective Toevaluatetheefficacyandsafetyoflevofloxacincombinedwithazithromycinonrefractoryrespiratoryinfectionsinelderpatients. Methods Atotalof68elderpatientswithrefractoryrespiratoryinfectionsinourhospitalfromFebruary2005toSeptember2010wererandomlydividedintotwogroupstreatmentgroup(n=34)andcontrolgroup(n=34).Thepatientsintreatmentgroupweretreatedwithlevofloxacincombinedwithazithromycin;whilethepatientsinthecontrolgroupweretreatedwithlevofloxacinalone.Thetotaltreatmentperiodsofbothgroupswere15days.Thetherapeuticefficacy,eradicationrateofpathogensandtherateofaelversereactionswereobserved. Results Thetherapeuticeffectratewas64.71%inthetreatmentgroupand32.35%inthecontrolgroup,andthedifferencebetweenthetwogroupswasstatisticallysignificant(P0.05). Conclusion LevofloxacincombinedwithAzithromyciniseffectiveonrefractoryrespiratorytractinfectioninelderpatients,whichcaneffectivelyremovethebacteriawithfewadversereaction.

References

[1]   穆魁津, 何权瀛. 肺部感染[M]. 北京: 北京医科大学中国协和医科大学联合出版社, 1996: 647-649.
[2]   中国人民解放军总后勤部卫生部. 临床疾病治愈诊断依据治愈好转标准[S]. 2版. 北京: 人民军医出版社, 2002: 47-48.
[3]   马壮. 老年肺炎的病原学特点与治疗[J]. 解放军保健医学杂志, 2005, 7(2): 120-121.
[4]   李鸿雁, 夏前明. 细菌生物被膜与难治性呼吸道感染[J]. 中国抗感染化疗杂志, 2004, 4(3): 190-192.
[5]   Flemming HC, Neu TR, Wozniak DJ. The EPS matrix: the"house of biofilm cells"[J]. J Bacteriol, 2007, 189(22): 7945-7947.
[6]   谢红梅, 胡必杰, 周昭彦, 等. 铜绿假单胞菌生物膜形成影响因素的研究[J]. 中华医院感染学杂志, 2007, 17(12): 1475-1477.
[7]   Musk DJ Jr, Hergenrother PJ. Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an ?in vitro? model of drug delivery to the human lung [J]. J Appl Microbiol, 2008, 105(2): 380-388.
[8]   王晓霞, 梅青, 黄维胜, 等. 国内左氧氟沙星制剂的开发与临床应用[J]. 中国药师, 2007, 10(3): 279.
[9]   聂大平, 董枫, 石宏宴. 左氧氟沙星、环丙沙星单用和联合其他抗菌药物对铜绿假单胞菌防突变浓度的研究[J]. 中国感染控制杂志,2007, 11(06). 397-400.
[10]   Hoffmann N, Lee B. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary growth-phase killing of Pseudomonas aeruginosa and attenuates chronic paeruginosa lung infection in Cftr mice [J]. Antimicrob Agents Chemother, 2007, 51(10): 3677-3687.
[11]   Rasmussen TB, Bjarnsholt T, Skindersoe ME, et al. Screening for quorum sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector[J]. J Bacteriol, 2005, 187 (5): 1799-1814.
[12]   Martinez JA, Horcajada JP, Alemla M, et al. Addition of a macrolide to a beta lactam based empirical antibiotic regimenis associated with lower inhospital mortality for patients with bacteremic pneumococcal pneumonia[J]. Clin Infect Dis, 2003, 36(4): 389-395.
[13]   Wozn Iak DJ, Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa[J]. Chest, 2004, 125 (Suppl): 62-69.
[14]   唐义平, 陈平. 罗红霉素联合敏感抗生素治疗铜绿假单胞菌生物被膜病的临床研究[J]. 华西医学, 2008, 23(4): 801-803.
[15]   方向群, 刘又宁. 亚胺培南联合罗红霉素对铜绿假单胞菌生物被膜的作用[J]. 中国抗生素杂志, 2009, 34(11): 688-690.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133